VHM — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Metagenomi Therapeutics is an in vivo genome editing company that uses genetic material sourced from natural environments (metagenomics) to develop a toolbox of editing tools for deletion, integration, and correction of genetic mutations.
BiotechDeep TechMedical DevicesBerkeley, US
Brian Thomas(Executive Officer, Director, Promoter)
BoardJak Knowles(Director)
Board seatAndrew Farquharson· per SEC Form D · $27.3M raise · filed Aug 2019
Co-investorsCatalio Capital Management, LPRA CapitalSozo VenturesAgent CapitalHumboldtInCube Ventures+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.